MM Dillon acted as sole advisor on Hawaii Biotech’s $10M capital raise. HB is developing vaccines for several infectious diseases. They are leaders in developing vaccines for West Nile virus, Tick borne virus, Zika virus and Chikungunya virus. The company has done over $50 in non-dilutive funding over the past few years,
About M.M. Dillon & Co.
M.M. Dillon & Co. (formerly CRT Investment Banking LLC) is an employee owned partnership where industry and product specialists collaborate closely to provide creative, idea-driven advice and solutions to its institutional and corporate clients. M.M. Dillon offers public and private financing, M&A advisory and restructuring advisory services. M.M. Dillon’s team of experienced professionals provides execution capabilities for companies across a range of industry sectors. The firm’s senior banking professionals have a minimum of 20 years of experience with major Wall Street firms.